Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitor for COVID-19 vaccine resistance evolution during clinical trials

9 Nov 2020

Abstract excerpt

Although less common than the evolution of antimicrobial drug resistance, vaccine resistance can and has evolved. How likely is it that COVID-19 vaccines currently in development will be undermined by viral evolution? We argue that this can be determined by repurposing samples that are already being collected as part of clinical trials. Such information would be useful for prioritizing investment among candidate...

Topics

Join the communities discussing this publication.

Bacterial Infections and Vaccines
Pneumonia and Respiratory Infections
SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33166303
DOI: 10.1371/journal.pbio.3001000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitor for COVID-19 vaccine resistance evolution during clinical trialsPMID 33166303Read ↗

Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistanceSemantic proximity Read ↗

The race between vaccination and evolution of COVID-19 variantsSemantic proximity Read ↗

Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics.Semantic proximity Read ↗

COVID-19 vaccines: breaking record times to first-in-human trialsSemantic proximity Read ↗

Vaccine hesitancy promotes emergence of new SARS-CoV-2 variantsSemantic proximity Read ↗

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19Semantic proximity Read ↗

Omicron variant evolution on vaccines and monoclonal antibodiesSemantic proximity Read ↗

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical frameworkSemantic proximity Read ↗

Rapid Generation of Medical Countermeasure Candidates Via Computational Variation AnalysisSemantic proximity Read ↗

Rapid viral quasispecies evolution: implications for vaccine and drug strategies.Semantic proximity Read ↗

Future prospects for the treatment of rapidly evolving viral pathogens: insights from evolutionary biology.Semantic proximity Read ↗

Vaccines alone cannot slow the evolution of SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.